Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2. Of the 448 patients randomly assigned to treatment, 433 were assessable. Treatment A ...
Intelliport System Cleared to Improve IV Bolus Management BD announced that the Food and Drug Administration (FDA) has cleared the BD Intelliport Medication Management System, a management system for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results